Institutional owners may take dramatic actions as Coherus BioSciences, Inc.'s (NASDAQ:CHRS) recent 12% drop adds to one-year losses

By Yahoo! Finance | Sep 20, 2024 at 06:34 AM EST

Analyzing analyst forecasts and ownership data can help predict a company's future performance. Institutional investors, holding 65% of Coherus BioSciences, greatly impact stock prices. With hedge funds and top shareholders involved, assessing different investor types is crucial for informed investment decisions.

Did you find this insightful?

Bad

Just Okay

Amazing

We are preparing, please wait

New Alert

Select an alert type

Sentiment Spike

Send email alert if news sentiment changes significantly

Mentions Spike

Send email alert if has a surge in mentions

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.